BTS
CLMT icon

BB&T Securities’s Calumet Specialty Products CLMT Stock Holding History

BB&T Securities’s Portfolio CLMT Stock Details CLMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-57,287
Closed -$366K – 1492
2018
Q3 		$366K Sell
57,287
-11,271
-16% -$80K ﹤0.01% 1238
2018
Q2 		$510K Buy
+68,558
New +$515K 0.01% 1067

Other funds holding CLMT

AAA
Adams Asset Advisors Dallas, Texas $882M AUM 42% 1-Year Est. Return
DMK
David M. Knott $275M AUM 59.23% 1-Year Est. Return
SCM
SCW Capital Management Dallas, Texas $44M AUM 39.16% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
WWM
Windsor Wealth Management Indianapolis, Indiana $546M AUM 16.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BC
Barnett & Company Chattanooga, Tennessee $135M AUM 27.14% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return
IECM
Intrinsic Edge Capital Management Chicago, Illinois $967M AUM 94.27% 1-Year Est. Return

BB&T Securities's CLMT Position: Q4 2018 in Review

BB&T Securities sold out of Calumet Specialty Products (CLMT) in Q4 2018, closing a stake of 57,287 shares — an estimated $366K sold.

BB&T Securities first reported a position in CLMT in Q2 2018 and held it in 2 quarters. The position peaked at $510K in Q2 2018. 64 funds tracked by Wall St. Rank hold CLMT as of Q4 2018.

  • BB&T Securities reported no remaining Calumet Specialty Products position as of Q4 2018 after selling out during the quarter.
  • BB&T Securities sold 57,287 Calumet Specialty Products shares in Q4 2018, an estimated $366K.
  • BB&T Securities first reported a position in Calumet Specialty Products in Q2 2018 and held it in 2 quarters.
  • BB&T Securities's Calumet Specialty Products position peaked at $510K in Q2 2018.
  • 64 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q4 2018.

Based on BB&T Securities's 13F filing for Q4 2018, filed 4 Feb 2019.